Argus raised the firm’s price target on Elevance Health (ELV) to $465 from $450 and keeps a Buy rating on the shares. The company’s results ...

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

Elevance Health saw net income fall 2.9% to $2.2 billion during the first quarter, the insurer announced Tuesday.

such as public health epidemics and pandemics, and other catastrophes; the impact of new or changes in existing federal, state and international laws or regulations, including laws and regulations ...

Q1 2025 Management View CEO Gail Boudreaux stated that Elevance Health began 2025 with focus and momentum, highlighting ...

Elevance Health brought in $2.2 billion in profit for the first quarter of 2025, a figure that surpassed Wall Street's ...

Shares of Elevance Health Inc. ELV slid 1.66% to $421.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 ...

Elevance Health Inc. (NYSE: ELV) ended the first quarter of 2025 with better-than-expected financials. The company identified home health as one of its ...

Despite rising costs in its health plans, Elevance Health reported more than $2 billion in first quarter net income thanks to growth across its health plans and Carelon health services business.

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best stocks that will always grow. Threats of an impending recession are looming over ...